Trained in haematology–oncology and a specialist researcher in cancer genetics, Olufunmilayo I Olopade (Department of Medicine, University of Chicago, Chicago, IL, USA) has spent almost three decades working with colleagues in Nigeria and across the world to advance global understanding of the role of genetics in determining risk and progression in early-onset breast cancer.